Testicular germ cell tumours: The paradigm of chemo-sensitive solid tumours
Authors:
- 1 December 2005
- journal article
- review article
- Published by Elsevier in The International Journal of Biochemistry & Cell Biology
- Vol. 37 (12) , 2437-2456
Abstract
No abstract availableKeywords
This publication has 186 references indexed in Scilit:
- Paclitaxel Treatment of Breast Cancer Cell Lines Modulates Fas/Fas Ligand Expression and Induces Apoptosis Which Can Be Inhibited through the CD40 ReceptorOncology, 2004
- Reduced levels of XPA, ERCC1 and XPF DNA repair proteins in testis tumor cell linesInternational Journal of Cancer, 2004
- Disruption of the Fanconi anemia–BRCA pathway in cisplatin-sensitive ovarian tumorsNature Medicine, 2003
- Identification and Characterization of HIPK2 Interacting with p73 and Modulating Functions of the p53 Familyin VivoJournal of Biological Chemistry, 2002
- Defining the molecular basis of Arf and Hdm2 interactionsJournal of Molecular Biology, 2001
- Association of p19ARF with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53The EMBO Journal, 1999
- Sensitivity of testis tumour cells to chemotherapeutic drugs: Role of detoxifying pathwaysEuropean Journal of Cancer, 1996
- A role for CD95 ligand in preventing graft rejectionNature, 1995
- Programmed cell death in response to chemotherapeutic agents in human germ cell tumour linesEuropean Journal of Cancer, 1995
- Deficient repair of cisplatin-DNA adducts identified in human testicular teratoma cell lines established from tumours from untreated patientsEuropean Journal of Cancer, 1994